Grammar:           DataElement 6.0
Namespace:         brca
Description:       "SHR implementation of ASCO requirements."
Uses:              shr.core, shr.entity, oncocore, shr.base
CodeSystem:        UCUM = http://unitsofmeasure.org
CodeSystem:        LNC = http://loinc.org
CodeSystem:        SCT = http://snomed.info/sct
CodeSystem:        MTH = http://ncimeta.nci.nih.gov

Entry:             BreastSite
Parent:            AnatomicalLocationStructured
Description:       "A body site specific to the breast structure."
                   AnatomicalLocationOrLandmarkCode from BreastSiteVS (required)
                   Laterality 1..1
                   DistanceFromLandmark[Distance].Units = UCUM#cm
                   AnatomicalDirection 0..0

Entry:             BreastSpecimen
Parent:            Specimen
Description:       "Specimen resulting from biopsy or excision of breast and surrounding tissue."
Property:          ColdIschemiaTime 0..1
                   Type from BreastSpecimenTypeVS (required)
                   CollectionMethod from BreastSpecimenCollectionMethodVS (required)
                   CollectionSite[AnatomicalLocation][AnatomicalLocationStructured] substitute BreastSite
                   SourceSpecimen[Specimen] substitute BreastSpecimen

Element:           ColdIschemiaTime
Concept:           LNC#44778-9
Description:       "The time period between the chilling of a tissue or tissue sample and the time it is warmed."
Value:             TimePeriod

Element:           MorphologyBehavior
Description:       "A description of the morphology and behavioral characteristics of the cancer."
Value:             concept

Entry:             BreastCancerDisorderPresent
Parent:            CancerDisorderPresent
Concept:           SCT#126926005 "Neoplasm of breast (disorder)"
Description:       "Diagnosis of cancer originating in the tissues of the breast, and potentially spread to other organs of the body."
Property:          MorphologyBehavior 0..1
                   FindingTopicCode from BreastCancerTypeVS (required)
                   FindingMethod from BreastCancerDetectionVS (preferred)
                   AnatomicalLocation[AnatomicalLocationStructured] substitute BreastSite
                   StageInformation.StageDetail[Observation] substitute BreastCancerStageInformation
                   MorphologyBehavior from MorphologyBehaviorVS (required)

Entry:             BreastCancerStageInformation
Parent:            CancerStageInformation
Concept:           MTH#C2216702 "Malignant Neoplasm of Breast Staging"
Description:       "The stage of a breast cancer. The panel should not include both a DCISNuclearGrade and a BreastCancerHistologicGrade, since the latter implies an invasive cancer."
                   FindingTopicCode = MTH#C2216702 "Malignant Neoplasm of Breast Staging"
                   SpecificFocusOfFinding[InformationItem] substitute BreastCancerDisorderPresent
                   PanelMembers.Observation
                   includes HER2ReceptorStatus 0..1
                   includes EstrogenReceptorStatus 0..1
                   includes ProgesteroneReceptorStatus 0..1
                   includes DCISNuclearGrade 0..1
                   includes BreastCancerHistologicGrade 0..1

Entry:             HER2ReceptorStatus
Parent:            CodedLaboratoryObservation
Concept:           LNC#48676-1 "HER2 [Interpretation] in Tissue"
Description:       "HER2 receptor status. HER2 is a member of the human epidermal growth factor receptor family of proteins and is encoded by the ERBB2 oncogene. HER2 is overexpressed in 20-30% of breast tumors, and is associated with an aggressive clinical course and poor prognosis. HER2 status (positive=present or overexpressed; negative=absent) is a factor in determining prognosis and treatment options."
                   FindingResult from PositiveNegativeEquivocalVS (required)
                   FindingTopicCode = LNC#48676-1 "HER2 [Interpretation] in Tissue"
                   FindingMethod 0..0
                   NonIndependentFinding 0..0
                   Specimen substitute BreastSpecimen
                   PanelMembers.Observation
                   includes HER2byIHC 0..*
                   includes HER2byFISH 0..*
                   DiagnosticService = #pathology

Entry:             HER2byIHC
Parent:            CodedLaboratoryObservation
Concept:           LNC#85319-2
Description:       "HER2 presence in Breast cancer specimen by Immunohistochemistry (IHC)."
                   FindingResult from HER2byIHCScoreVS (required)
                   FindingTopicCode = LNC#85319-2 "HER2 [Presence] in Breast cancer specimen by Immune stain"
                   ExceptionValue from HER2byIHCScoreNullVS (required)
                   FindingMethod 0..0
                   NonIndependentFinding
                   includes CompleteMembraneStainingPercent 0..1
                   Interpretation from PositiveNegativeEquivocalVS (required)
                   Specimen substitute BreastSpecimen
                   PanelMembers 0..0
                   DiagnosticService = #pathology

Element:           CompleteMembraneStainingPercent
Parent:            QuantitativeNonIndependentFinding
Concept:           LNC#85328-3 "Cells.HER2 uniform intense membrane staining/100 cells"
Description:       "Percentage of cells with uniform intense complete membrane staining."
                   ReferenceRange 0..0

Entry:             HER2byFISH
Parent:            LaboratoryObservation
Concept:           LNC#85318-4
Description:       "HER2 receptor status as determined by single-probe or dual-probe Fluorescence In Situ Hybridization (FISH)."
                   FindingResult 0..0
                   FindingTopicCode = LNC#85318-4 "HER2 [Presence] in Breast cancer specimen by FISH"
                   ExceptionValue 0..0
                   FindingMethod from HER2FISHMethodVS (required)
                   NonIndependentFinding
                   includes AverageHER2SignalsPerCell 0..1
                   includes AverageCEP17SignalsPerCell 0..1
                   includes HER2toCEP17Ratio 0..1
                   Interpretation from PositiveNegativeEquivocalVS (required)
                   Specimen substitute BreastSpecimen
                   PanelMembers 0..0
                   DiagnosticService = #pathology

Element:           AverageHER2SignalsPerCell
Parent:            QuantitativeNonIndependentFinding
Concept:           LNC#74860-8
Description:       "Average number of HER2 signals per cell"
                   ReferenceRange 0..0

Element:           AverageCEP17SignalsPerCell
Parent:            QuantitativeNonIndependentFinding
Concept:           LNC#74861-6
Description:       "Average number CEP17 signals per cell (dual probe only)"
                   ReferenceRange 0..0

Element:           HER2toCEP17Ratio
Parent:            QuantitativeNonIndependentFinding
Concept:           LNC#49683-6
Description:       "HER2 to CEP17 Ratio (dual probe only)"
                   ReferenceRange 0..0

Entry:             EstrogenReceptorStatus
Parent:            CodedLaboratoryObservation
Concept:           LNC#16112-5 "Estrogen receptor [Interpretation] in Tissue"
Description:       "Estrogen receptor alpha is the predominant estrogen receptor expressed in breast tissue and is overexpressed in around 50% of breast carcinomas. ER status (positive=present or overexpressed; negative=absent) is a factor in determining prognosis and treatment options.
The current approach is that positive/negative designation is a value, even though that value is (in fact) an interpretation of evidence (NuclearPositivity and AverageStainingIntensity)."
                   FindingResult from PositiveNegativeVS (required)
                   FindingTopicCode = LNC#16112-5
                   NonIndependentFinding
                   includes NuclearPositivity 0..1
                   includes AverageStainingIntensity 0..1
                   Specimen substitute BreastSpecimen
                   PanelMembers 0..0
                   DiagnosticService = #pathology

Entry:             ProgesteroneReceptorStatus
Parent:            CodedLaboratoryObservation
Concept:           LNC#16113-3
Description:       "Progesterone receptor status is a factor in determining prognosis and treatment options. The value is the percentage of cells that test (stain) positive for the presence of a receptor. The interpretation of positive or negative (found in the interpretation property) is based on the staining percentage, and may take into account the staining intensity.
Based on discussion with Cancer Interoperability Group subject matter experts, there was insufficient rationale to include the following components in the data model: StainingControl, PrimaryAntibody, Allred Score (both total and component scores). We are seeking feedback on whether or not those components should be included in this model."
                   FindingResult from PositiveNegativeVS (required)
                   FindingTopicCode = LNC#16113-3 "Progesterone receptor [Interpretation] in Tissue"
                   NonIndependentFinding
                   includes NuclearPositivity 0..1
                   includes AverageStainingIntensity 0..1
                   Specimen substitute BreastSpecimen
                   PanelMembers 0..0
                   DiagnosticService = #pathology

Element:           NuclearPositivity
Parent:            NonIndependentFinding
Description:       "The percentage of cells that test (stain) positive for the presence of a receptor.
We are seeking feedback on whether nuclear positivity should be an exact percentage or a range of percentages. As currently defined, an exact nuclear positivity could be represented by a zero-width range, where the lower and upper bounds would be the same number."
                   FindingResult only Range

Element:           AverageStainingIntensity
Parent:            CodedNonIndependentFinding
Concept:           SCT#444775005 "Average intensity of positive staining neoplastic cells (observable entity)"
Description:       "The degree or magnitude of staining (nuclear positivity) across cells in the specimen."
                   FindingResult from StainingIntensityVS (required)

Entry:             DCISNuclearGrade
Parent:            SimpleCodedLaboratoryObservation
Concept:           MTH#C18513
Description:       "An evaluation of the size and shape of the nucleus in tumor cells and the percentage of tumor cells that are in the process of dividing or growing. Cancers with low nuclear grade grow and spread less quickly than cancers with high nuclear grade."
                   FindingResult from NuclearGradeVS (required)
                   FindingTopicCode = MTH#C18513
                   Specimen substitute BreastSpecimen
                   DiagnosticService = #pathology

Entry:             BreastCancerHistologicGrade
Parent:            CancerHistologicGrade
Concept:           LNC#44648-4
Description:       "The Elston Grade/Nottingham Score, representative of the aggressive potential of the tumor. Well differentiated cells (Grade 1) look similar to normal cells and are usually slow growing, while poorly differentiated cells (Grade 3) look very different than normal and are fast-growing."
                   FindingResult from NottinghamCombinedGradeVS (required)
                   FindingTopicCode = LNC#44648-4
                   ExceptionValue from NottinghamNullVS (required)
                   NonIndependentFinding
                   includes TubuleFormationScore 0..1
                   includes NuclearPleomorphismScore 0..1
                   includes MitoticCountScore 0..1
                   Specimen substitute BreastSpecimen
                   PanelMembers 0..0
                   DiagnosticService = #pathology

Element:           TubuleFormationScore
Parent:            CodedNonIndependentFinding
Concept:           LNC#85321-8 "Granular differentiation"
Description:       "Glandular differentiation [Score] in Breast cancer specimen Qualitative by Nottingham."
                   FindingResult from TubuleFormationScoreVS (required)
                   ExceptionValue from NottinghamComponentNullVS (required)

Element:           NuclearPleomorphismScore
Parent:            CodedNonIndependentFinding
Concept:           LNC#44645-0
Description:       "Nuclear pleomorphism in Breast tumor Qualitative by Nottingham."
                   FindingResult from NuclearPleomorphismScoreVS (required)
                   ExceptionValue from NottinghamComponentNullVS (required)

Element:           MitoticCountScore
Parent:            CodedNonIndependentFinding
Concept:           LNC#85300-2
Description:       "Mitotic rate [Score] in Breast cancer specimen Qualitative by Nottingham."
                   FindingResult from MitoticCountScoreVS (required)
                   ExceptionValue from MitoticCountScoreNullVS (required)

Entry:             OncotypeDxInvasiveRecurrenceScore
Parent:            SimpleLaboratoryObservation
Concept:           MTH#C1709318
Description:       "The Oncotype DX test for invasive breast cancer examines the activity of 21 genes in a patientâ€™s breast tumor tissue to provide personalized information for tailoring treatment based on the biology of their individual disease. The value from 0 to 100 indicates the estimated risk of recurrence, with the highest risk indicated by a score greater than 31.
No LOINC code currently exists for this test. We are seeking feedback on the value of separating OncotypeDx scores for DCIS and invasive breast carcinomas. Does it make more sense to report the OncotypeDx as a single score, regardless of the type of cancer?"
                   FindingResult only IntegerQuantity
                   FindingTopicCode = MTH#C1709318
                   Interpretation from RecurrenceRiskScoreInterpretationVS (required)
                   Specimen substitute BreastSpecimen
                   DiagnosticService = #pathology

Entry:             OncotypeDxDCISRecurrenceScore
Parent:            SimpleLaboratoryObservation
Concept:           MTH#C3898101
Description:       "The Oncotype DX test for DCIS (Ductal Carcinoma in Situ) breast cancer. Risk scores range from 0 to 100 with the following interpretations: 0-38: Low-Risk, 39-54: Intermediate-Risk, 55+: High-Risk.
No LOINC code currently exists for this test. We are seeking feedback on the value of separating OncotypeDx scores for DCIS and invasive breast carcinomas. Does it make more sense to report the OncotypeDx as a single score, regardless of the type of cancer?"
                   FindingResult only IntegerQuantity
                   FindingTopicCode = MTH#C3898101
                   Interpretation from RecurrenceRiskScoreInterpretationVS (required)
                   Specimen substitute BreastSpecimen
                   DiagnosticService = #pathology

Entry:             ProsignaRecurrenceScore
Parent:            SimpleLaboratoryObservation
Concept:           LNC#76544-6
Description:       "Breast cancer genomic signature assay for 10-year risk of distant recurrence score calculated by Prosigna.
The Prosigna Score is reported on a 0-100 scale (referred to as ROR Score or Risk of Recurrence Score in the literature), which is correlated with the probability of distant recurrence at ten years for post-menopausal women with hormone receptor positive, early stage breast cancer."
                   FindingResult only IntegerQuantity
                   FindingTopicCode = LNC#76544-6
                   Interpretation from RecurrenceRiskScoreInterpretationVS (required)
                   Specimen substitute BreastSpecimen
                   DiagnosticService = #pathology

Entry:             MammaprintRecurrenceScore
Parent:            SimpleLaboratoryObservation
Concept:           MTH#C2827401
Description:       "Breast cancer genomic signature assay for 10-year risk of distant recurrence score calculated by Mammaprint.
In the United States, MammaPrint can only be used on cancers that are stage I or stage II, invasive, smaller than 5 centimeters, and estrogen-receptor-positive or -negative. Scores range from -1.0 to +1.0, with scores less than 0 indicating high risk, and scores greater than 0 indicating low risk.
The is currently no LOINC code for Mammaprint test."
                   FindingResult only Quantity
                   FindingTopicCode = MTH#C2827401
                   Interpretation from RecurrenceRiskScoreInterpretationVS (required)
                   Specimen substitute BreastSpecimen
                   DiagnosticService = #pathology
